Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2007 FY- Text added to 2008 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abuse, acute, affirmativevote, ALFREDG, allegedly, ameeting, Amerique, AMT, andissued, andqualitative, andsell, anintegral, ARCALYST, ARCALYSTand, ARCALYSTfor, ARCALYSTproduct, areexercisable, arequirement, arerecognized, Asia, assumption, Australia, automotive, basedon, beracizumab, berecovered, bill, bodily, bond, breadth, break, Bridgewater, California, card, catchup, CHARLESA, choroidal, civil, CNV, cohort, Columbia, combinedvoting, commercializeproduct, commonly, CommonStock, compensatory, contractresearch, cooling, criminal, DA, decline, declined, default, deferral, diagnostic, disrupt, disruptive, distributor, du, ease, Eastview, EITF, EMEA, entireVelociSuite, entry, ERICM, EUR, excreted, extinguishment, false, FAS, flare, FSP, GEORGEL, heldby, hierarchy, home, Hope, host, Housing, imprisonment, incidence, inconsequential, inexpensive, injured, intangible, Intermittent, Jersey, JOSEPHL, journalNature, judicial, knowingly, laser, Latin, legislation, lesion, MAA, main, Maine, materialeffect, membrane, Minnesota, Modernization, monetary, MURRAYA, Nerve, Nevada, NGF, Nineteen, Nord, notion, NSAID, occasion, ofall, ofthe, ofVelocImmune, OncoMed, orconsolidation, orVelocImmune, ourChief, ourcommon, ourVelociMab, ourVelocImmune®technology, ourVelociSuite, Pacific, page, persuasive, PharmD, preparatory, prime, PRN, prompt, qualitative, quantitative, reaction, rebate, recurring, refund, regularly, relevant, remission, remit, remuneration, repaid, Reseller, residential, revoke, revoked, rolling, sample, separateVelociGene, sharesentitled, shift, Social, startup, stimuli, Stockand, Subscription, subsidiary, thatshareholder, Theaccompanying, theapproval, TheCompany, theintroduction, thesesix, theVelociGene, TheVelociMouse, thing, threatening, timelynotice, title, tohold, unclear, University, unknown, unobservable, useVelocImmune, usingVelocImmune, VANILLA, VelociSuite, VELOUR, vendor, VENICE, Vermont, VINCI, Virginia, VITAL, West, whetherthe, wholesale, willfully
Removed:
adenocarcinoma, affirmative, APB, Arthur, call, calling, central, complication, comprised, consecutive, consolidation, converted, Countering, DC, deadline, death, decision, derive, DR, engineered, eventually, exploring, failed, feature, fine, fluid, foot, Frameworkissued, Gamble, hormone, impede, inhibiting, inhibitor, insulin, intended, isolation, IssueNo, Macugen, macula, moderate, mutation, narrowing, notification, onForm, onpage, originally, orphan, outplacement, pathogenic, pocket, preexisting, prevalent, Procter, productivity, promoting, pursued, recipient, redeem, regular, release, remained, remove, Room, Ryan, stimulate, Street, succeed, surrender, surrendered, systemic, systemically, theForm, threat, toRule, Tularik, voluntary, workforce
Valuein 2007 FY filing- Value in 2008 FY filing
Original filings
Filing view